C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk

被引:0
作者
Kosmala, Aleksander [1 ]
Hasenauer, Natalie [1 ]
Serfling, Sebastian E. [1 ]
Michalski, Kerstin [1 ]
Froehlich, Matthias [2 ]
Dreher, Niklas [1 ,3 ]
Hartrampf, Philipp E. [1 ]
Higuchi, Takahiro [1 ,4 ]
Buck, Andreas K. [1 ]
Weich, Alexander [2 ,5 ]
Reiter, Theresa [6 ,7 ]
Werner, Rudolf A. [1 ,5 ,8 ,9 ]
机构
[1] Univ Hosp Wurzburg, Dept Nucl Med, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany
[2] Univ Hosp Wurzburg, Internal Med 2, Wurzburg, Germany
[3] Univ Augsburg, Fac Med, Nucl Med, Augsburg, Germany
[4] Okayama Univ, Fac Med Dent & Pharmaceut Sci, Okayama, Japan
[5] Univ Hosp Wurzburg, European Neuroendocrine Tumor Soc Ctr Excellence E, NET Zentrum Wurzburg, Wurzburg, Germany
[6] Univ Hosp Wurzburg, Internal Med 1, Wurzburg, Germany
[7] Tech Univ Munich, German Heart Ctr Munich, Dept Electrophysiol, Munich, Germany
[8] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA
[9] Goethe Univ Frankfurt, Univ Hosp, Dept Nucl Med, Clin Diag & Intervent Radiol & Nucl Med, Frankfurt, Germany
来源
THERANOSTICS | 2025年 / 15卷 / 03期
基金
日本学术振兴会;
关键词
68Ga]Ga-PentixaFor; C-X-C motif chemokine receptor 4; CXCR4; atherosclerosis; cardiovascular risk factors; molecular imaging; CELL LUNG-CANCER; CXCR4; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; GA-68; AXIS;
D O I
10.7150/thno.102910
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: To establish the extent, distribution and frequency of in-vivo vessel wall [68Ga]Ga-PentixaFor uptake and to determine its relationship with calcified atherosclerotic plaque burden (CAP) and cardiovascular risk factors (CVRF). Methods: 65 oncological patients undergoing [Ga-68]Ga-PentixaFor PET/CT were assessed. Radiotracer uptake (target-to-background ratio [TBR]) and CAP burden (including number of CAP sites, calcification circumference and thickness) in seven major vessel segments per patient were determined. We then investigated associations of vessel wall uptake with CAP burden, cardiovascular risk (CVRF and European Society of Cardiology [ESC] SCORE2/SCORE2-OP risk chart) and image noise (determined by coefficient of variation [CoV] from unaffected liver parenchyma). Results: We identified 1292 sites of high focal [Ga-68]Ga-PentixaFor uptake (PentixaFor+ sites) in the vessel wall in 65/65 (100%) patients, with concomitant calcification in 385/1292 (29.8%) sites. There were no significant associations between vessel wall uptake and CAP burden (number of PentixaFor+ sites: r <= 0.18, P >= 0.14; PentixaFor+ TBR: r <= 0.08, P >= 0.54). The number of PentixaFor+ sites showed a moderate correlation with cardiovascular risk (ESC SCORE2/SCORE2-OP, r = 0.30; number of CVRF, r = 0.26; P = 0.04, respectively), but failed to reach significance for PentixaFor+ TBR (r <= 0.18, P >= 0.22). In univariable regression analysis, body mass index (odds ratio [OR] 1.08, 95%-confidence interval [CI] 1.02-1.14) and CoV (OR, 1.07; CI, 1.05-1.10) were linked to TBR and the number of PentixaFor+ sites (P < 0.01, respectively), while injected activity was only associated with the latter imaging parameter (OR, 0.99; CI, 0.98-1.00; P = 0.04). In multivariable regression, injected activity (OR, 1.00; CI, 0.99-1.00) and CoV (OR, 1.06; CI, 1.06-1.07) remained significantly associated with the number of PentixaFor+ sites (P < 0.01, respectively). CoV, however, was the only parameter significantly linked to PentixaFor+ TBR on multivariable analysis (OR, 1.02; CI, 1.01-1.03; P < 0.01). Conclusion: On a visual and quantitative level, high focal [Ga-68]Ga-PentixaFor uptake in the arterial tree was not consistently linked to vessel wall calcification or cardiovascular risk. Image noise, however, may account for a substantial portion of apparent vessel wall uptake.
引用
收藏
页码:804 / 814
页数:11
相关论文
共 45 条
  • [21] Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells
    Karpova, Darja
    Ritchey, Julie K.
    Holt, Matthew S.
    Abou-Ezzi, Grazia
    Monlish, Darlene
    Batoon, Lena
    Millard, Susan
    Spohn, Gabriele
    Wiercinska, Eliza
    Chendamarai, Ezhil
    Yang, Wei
    Christ, Stephanie
    Gehrs, Leah
    Schuettpelz, Laura G.
    Dembowsky, Klaus
    Pettit, Allison R.
    Rettig, Michael P.
    Bonig, Halvard
    DiPersio, John F.
    [J]. BLOOD, 2017, 129 (21) : 2939 - 2949
  • [22] Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT
    Kircher, Malte
    Tran-Gia, Johannes
    Kemmer, Luisa
    Zhang, Xiaoli
    Schirbel, Andreas
    Werner, Rudolf A.
    Buck, Andreas K.
    Wester, Hans-Juergen
    Hacker, Marcus
    Lapa, Constantin
    Li, Xiang
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (05) : 751 - 756
  • [23] CXCR4-directed theranostics in oncology and inflammation
    Kircher, Malte
    Herhaus, Peter
    Schottelius, Margret
    Buck, Andreas K.
    Werner, Rudolf A.
    Wester, Hans-Juergen
    Keller, Ulrich
    Lapa, Constantin
    [J]. ANNALS OF NUCLEAR MEDICINE, 2018, 32 (08) : 503 - 511
  • [24] Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging
    Kosmala, Aleksander
    Seifert, Simone
    Schneid, Simone
    Dreher, Niklas
    Higuchi, Takahiro
    Weich, Alexander
    Serfling, Sebastian E. E.
    Hartrampf, Philipp E. E.
    Einsele, Hermann
    Buck, Andreas K. K.
    Topp, Max S. S.
    Duell, Johannes
    Werner, Rudolf A. A.
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2023, 25 (04) : 758 - 764
  • [25] Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors
    Kosmala, Aleksander
    Serfling, Sebastian E.
    Michalski, Kerstin
    Lindner, Thomas
    Schirbel, Andreas
    Higuchi, Takahiro
    Hartrampf, Philipp E.
    Derlin, Thorsten
    Buck, Andreas K.
    Weich, Alexander
    Werner, Rudolf A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 3011 - 3021
  • [26] High-Contrast CXCR4-Targeted 18F-PET Imaging Using a Potent and Selective Antagonist
    Kwon, Daniel
    Lozada, Jerome
    Zhang, Zhengxing
    Zeisler, Jutta
    Poon, Richel
    Zhang, Chengcheng
    Roxin, Aron
    Lin, Kuo-Shyan
    Perrin, David
    Benard, Francois
    [J]. MOLECULAR PHARMACEUTICS, 2021, 18 (01) : 187 - 197
  • [27] [68Ga] Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F] FDG and laboratory values
    Lapa, Constantin
    Schreder, Martin
    Schirbel, Andreas
    Samnick, Samuel
    Kortuem, Klaus Martin
    Herrmann, Ken
    Kropf, Saskia
    Einsele, Herrmann
    Buck, Andreas K.
    Wester, Hans-Juergen
    Knop, Stefan
    Lueckerath, Katharina
    [J]. THERANOSTICS, 2017, 7 (01): : 205 - 212
  • [28] [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
    Lapa, Constantin
    Lueckerath, Katharina
    Rudelius, Martina
    Schmid, Jan-Stefan
    Schoene, Alexander
    Schirbel, Andreas
    Samnick, Samuel
    Pelzer, Theo
    Buck, Andreas K.
    Kropf, Saskia
    Wester, Hans-Juergen
    Herrmann, Ken
    [J]. ONCOTARGET, 2016, 7 (08) : 9288 - 9295
  • [29] Imaging Inflammation in Atherosclerosis with CXCR4-Directed [68Ga]PentixaFor PET/MRI-Compared with [18F]FDG PET/MRI
    Lu, Xia
    Calabretta, Raffaella
    Wadsak, Wolfgang
    Haug, Alexander R.
    Mayerhoefer, Marius
    Raderer, Markus
    Zhang, Xiaoli
    Li, Jingle
    Hacker, Marcus
    Li, Xiang
    [J]. LIFE-BASEL, 2022, 12 (07):
  • [30] R Foundation for Statistical Computing, 2022, R LANGUAGE ENV STAT, DOI DOI 10.59350/T79XT-TF203